○ Supporting 14 companies participating in BIO USA for four days from June 16 to 19
○ Co-hosting “Korea BioTech Partnership (KBTP)” to showcase Korea’s bio-industry excellence
The Gyeonggi Provincial Government, in partnership with the Gyeonggi-do Business & Science Accelerator (GBSA), is backing local SMEs and venture companies’ participation in the upcoming BIO USA exhibition in Boston, USA, from June 16 to 19.

Recognized as the world’s largest exhibition specializing in bio partnership, BIO USA provides an ideal platform for fostering global business partnerships and exchanges among bio-industry professionals.

Following public recruitment in April, Gyeonggi selected 14 participating companies—including TXINNO BioScience, SN BioScience, and Lmito Therapeutics—specializing in innovative drug research and high-value pharmaceuticals. These firms aim to expand their global technological business through the event.

On June 17, GBSA will co-host the official BIO USA side event, “Korea BioTech Partnership (KBTP) 2025,” alongside KOTRA, the Korea Planning & Evaluation Institute of Industrial Technology (KEIT), the Korea Biotechnology Industry Organization (Korea Bio), the Korea Exchange (KRX), and Invest Seoul. The event will be held at a conference hall near the exhibition venue to promote Korea’s bio-industry strengths. As BIO USA 2025’s official supplementary event, KBTP will offer insights into Korea’s biotech industry environment, capital markets, and IPO cases while facilitating mutual understanding with international biotech firms. Presenters from Korea Investment Partners, Samsung Securities, and BKL will discuss the Korean biotech market, while Yuhan Corporation, ABLE Bio, and Roche will share perspectives on industry growth and insights from global business models.

Eom Ki-man, Director of Gyeonggi’s Bio Industry Division, stated, “Commercializing bio-industry businesses is an immense hurdle for individual companies, which is why partnerships are essential to their success.” He added, “We hope our support program for global technology commercialization of the bio-industry, which encompasses our assistance for this year’s BIO USA, will help local SMEs and venture companies broaden their business horizons. Gyeonggi remains committed to offering steadfast support for companies pursuing overseas expansion.”